Taken together, our findings that SphK1 protects but SphK2 promotes β-cell lipotoxicity suggest a new strategy by balancing between the signaling of SphK1 and SphK2 in β-cells for the prevention and treatment of diabetes. The gene discussed is SPHK1; the disease is diabetes mellitus.